Why Apyx Medical Corporation’s (APYX) Stock Is Up 5.51%
As of Friday, October 09, Apyx Medical Corporation’s APYX share price has surged by 5.51%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Stock Evaluator: Apyx Medical Corporation (APYX)
Apyx Medical Corporation APYX
$2.61
0.11
4.40%
October 28, 2026 4:00:00 PM
EST
Volume: 34,756
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Commentary & Analysis
Why Apyx Medical Corporation’s (APYX) Stock Is Down 5.10%
As of Thursday, October 08, Apyx Medical Corporation’s APYX share price has dipped by 5.10%, which has investors questioning if this is right time to buy.Michael Rose
Why Apyx Medical Corporation’s (APYX) Stock Is Up 6.00%
As of Tuesday, September 29, Apyx Medical Corporation’s APYX share price has surged by 6.00%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Apyx Medical Corporation’s (APYX) Stock Is Down 7.09%
As of Monday, September 28, Apyx Medical Corporation’s APYX share price has dipped by 7.09%, which has investors questioning if this is right time to buy.Michael Rose
Why Apyx Medical Corporation’s (APYX) Stock Is Down 11.49%
As of Monday, September 28, Apyx Medical Corporation’s APYX share price has dipped by 11.49%, which has investors questioning if this is right time to buy.Omar Beirat
Financial Summary
| Share Statistics | APYX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $105.3 | $421.0 | 23% |
|
| Shares Out (Mil) | 43.9 | 40.7 | 45% |
|
| Institutional Ownership | 72.9% | 83.3% | 44% |
|
| Float (Mil) | 30.5 | 34.5 | 36% |
|
| Beta | 1.31 | 0.85 | 75% |
|
| Avg Daily Volume (000s) | 141 | 277 | 41% |
|
| Price Change (52-week) |
(22.1%) | 64.4% | 35% |
|
| Growth | APYX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 13.8% | 11.8% | 70% |
|
| Net Income (5yr) | 1.2% | (5.5%) | 41% |
|
| EPS (5yr) | 4.7% | 10.7% | 38 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 14.9% | (15.6%) | 72% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 6 | |
| Current EPS | ($0.093) | ($0.265) | ($0.252) | |
| Month Ago EPS | ($0.096) | ($0.272) | ($0.258) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | ($0.088) | ($0.268) | ($0.250) | |
| Year/Year Chg | 25.7% | (2.9%) | (63.4%) | |
| Financials | APYX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $58 | $141 | 21% |
|
| Net Income (TTM) (Mil) | ($9) | ($9) | 30% |
|
| EPS (TTM) | ($0.203) | ($0.400) | 33% |
|
| Operating Cash Flow (TTM) (Mil) | ($10) | ($2) | 20% |
|
| Net Cash Flow (TTM) (Mil) | ($2) | $1 | 38% |
|
| Long-Term Debt (Q1) (Mil) | $39 | $27 | 37% |
|
| Enterprise Value (Q1) (Mil) | $140 | $418 | 24% |
|
| Valuation | APYX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 10.00 | 2.50 | 91% |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | APYX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 63.5% | 59.3% | 76% |
|
| Net Margin | (14.8%) | (6.9%) | 18% |
|
| ROA | (14.5%) | (12.2%) | 23% |
|
| ROE | (96.4%) | (10.7%) | 9% |
|
| Liabilities to Assets | 81.8% | 47.2% | 76% |
|
| F-Score | 4 | 4 | 34% |
|
Apyx Medical Corporation did not pass any screens on 10/27/2026.
